Phase I/II Study of CBX-12 in Patients with Advanced or Metastatic Refractory Solid Tumors
The purpose of this phase I/II study is to evaluate the safety and feasibility of CBX-12 in patients with advanced or metastatic solid tumors, including pancreatic cancer.
Study ID: CBX-12-101
Trial Phase: Phase I/II
Trial Sponsor: Cybrexa Therapeutics
Therapies Used in This Trial: CBX-12